1-4 of 4
Keywords: urokinase-type plasminogen activator (uPA)
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biochem J (2011) 438 (1): 39–51.
Published: 27 July 2011
... pharmaceutical intervention with serine protease activity by targeting surface loops that undergo conformational changes during zymogen activation. © The Authors Journal compilation © 2011 Biochemical Society 2011 antibody cancer conformation immunofluorescence urokinase-type plasminogen activator...
Biochem J (2008) 415 (2): 265–273.
Published: 25 September 2008
... ntagonist causing cell d eath (BAD) protein cell death cell signalling cell survival mannose 6-phosphate (M6P)/insulin-like growth factor 2 receptor (IGF2R) urokinase-type plasminogen activator (uPA) MCs were seeded on to glass coverslips in 12-well plastic plates (Nunc) and cultured in...
Biochem J (2008) 412 (3): 447–457.
Published: 28 May 2008
... Biochemical Society 2008 cancer metastasis peptide phage display serine protease urokinase-type plasminogen activator (uPA) Serine proteases of the trypsin family (clan SA) have many physiological and pathophysiological functions. There is therefore extensive interest in generating specific...
Biochem J (2004) 381 (1): 203–212.
Published: 22 June 2004
... endocytosis receptor-associated protein (RAP) urokinase-type plasminogen activator (uPA) type-1 plasminogen activator inhibitor (PAI-1) platelet-derived growth factor-BB (PDGF-BB) The mosaic type-1 receptor sorLA/LR11 is a member of the Vps10p domain receptor family, which also contains sortilin...